Location: Home
  • search
  • go
  • News
  • 3/17/2025BeiGene and Amgen Launch Phase 1 Trial of Tarlatamab + YL201 in China
  • 3/17/2025HBM and Insilico Enter Strategic Deal to Advance AI-Driven Antibody Di...
  • 3/14/2025Recent Executive Moves
  • 3/14/2025Innovent's IBI311 Becomes First Chinese-Made IGF-1R Antibody Approved ...
  • 3/14/2025Zai Lab/Pfizer's BLA for Tivdak Accepted in China
  • 3/14/2025Fosun Pharma to Divest United Family Healthcare for $124.1M
  • 3/14/2025Pyrotech's PTT-936 Gains Approval for Clinical Trials in China for Adv...
  • 3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
  • 3/14/2025Roche's Itovebi (Inavolisib) Wins Approval in China for Advanced Breas...
  • 3/13/2025Insilico Medicine Secures $110M, Explores IPO Amid AI Drug Discovery B...
  • 3/13/2025China Issues Guidelines for Informatization of County-Level Healthcare...
  • 3/13/2025AskBio Receives FDA Regenerative Medicine Advanced Therapy Designation...
  • 3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...
  • 3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...
  • 3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...
  • 3/12/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (91...
  • 3/12/2025Pfizer's PD-L1 Targeting ADC Receives Clinical Trial Approval in China
  • 3/12/2025Eli Lilly Plans Late 2025 Launch of Weight Loss Drugs in China and Ind...
  • 3/12/2025CSPC Advances Phase II Trial of Nectin-4 ADC SYS6002 for Advanced HNSC...
  • 3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
  • 3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...
  • 3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
  • 3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...
  • 3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...
  • 3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...
  • 3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...
  • 3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis
  • 3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...
  • 3/10/2025Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx
  • 3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment
  • Page:19/53 Total number of articles:1573: [First][<<] [17] [18] [19] [20] [21] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group